Warner Lambert

Although controversy exists over the cholinergic involvement in AD dementia, as of 1993 the only AD therapy approved by the U.S. FDA was the cholinesterase inhibitor, tacrine [321-64-2] C 2H 4N2, sold as Cognex (Warner-Lambert). [Pg.96]

Nicotrol, developed by Cygaus Corp. and to be marketed by Warner-Lambert, is the fourth nicotine transdermal system to be approved ia the Uoited States. It dehvers nicotine only duriag wakiag hours to mimic better the habits of smokers (109). la oae coatroUed study, ao statistical differeaces ia efficacy and good tolerabihty were observed for the wakiag and continuous regimen (112). [Pg.231]

Thomas A. Pugsley Warner-Lambert / Parke-Davis... [Pg.361]

Wilbert, G. and De Angel is, J. U.S. Patent 2,998,450 August 29,1961 assigned to Warner-Lambert Pharmaceutical Company. [Pg.15]

Ercoli, A. and Gardi, R. U,S. Patent 3,529,060 September 15, 1970 assigned to Warner-Lambert Pharmaceutical Co,... [Pg.167]

F Activir (Warner-Lambert) Avyclor (Bioprogress) J Zovirax (Seimitomo-... [Pg.33]

See also in sourсe #XX -- [ Pg.148 ]

See also in sourсe #XX -- [ Pg.45 ]

See also in sourсe #XX -- [ Pg.43 , Pg.257 , Pg.260 ]

See also in sourсe #XX -- [ Pg.10 , Pg.32 , Pg.135 , Pg.199 , Pg.200 , Pg.240 ]

See also in sourсe #XX -- [ Pg.140 ]

See also in sourсe #XX -- [ Pg.15 , Pg.33 , Pg.201 ]

See also in sourсe #XX -- [ Pg.251 ]

See also in sourсe #XX -- [ Pg.420 , Pg.430 ]

See also in sourсe #XX -- [ Pg.336 ]

See also in sourсe #XX -- [ Pg.52 , Pg.226 ]

See also in sourсe #XX -- [ Pg.129 , Pg.132 ]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...